Streamlined Parallel Histopathology and NGS Workflows to Detect Clinically Relevant DNA and RNA Variants in Various Solid Tumor Indications
Our TSO500 NGS services provide pan-cancer genomic biomarker analysis of SNVs, InDels, CNVs, Fusions, TMB, and MSI to enable:
Using commercially available reference standards in our optimized and automated nucleic acid extraction, library construction, and sequencing workflows, we demonstrate the accuracy, sensitivity, and reproducibility of our TSO500 ctDNA NGS service
Download this white paper to learn more about our optimized protocol that retains and extracts longer RNA molecules without impacting DNA quality or yield.
Download Whitepaper
